IPH4102; An Anti-KIR3DL2 Monoclonal Antibody in Refractory Sezary Syndrome: Results From a Multicenter Phase 1 Trial

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 12
页数：3
相关论文
共 50 条
  • [1] IPH4102; An Anti-KIR3DL2 Monoclonal Antibody in Refractory Sezary Syndrome: Results from a Multicenter Phase 1 Trial
    Bagot, Martine
    Porcu, Pierluigi
    William, Basem M.
    Battistella, Maxime
    Vermeer, Maarten
    Whittaker, Sean
    Ram-Wolff, Caroline
    Khodadoust, Michael S.
    Sicard, Helene
    Azim, Hatem A., Jr.
    Kim, Youn H.
    BLOOD, 2018, 132
  • [2] IPH4102 (an anti-KIR3DL2 antibody) in refractory cutaneous T cell lymphoma
    Bagot, M.
    Porcu, P.
    Marie-Cardine, A.
    Battistella, M.
    Bensussan, A.
    Paturel, C.
    Bonnafous, C.
    Sicard, H.
    Azim, H.
    Kim, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S230 - S230
  • [3] First-in-human, open label, multicenter phase I of IPH4102, first-in-class humanized anti-KIR3DL2 monoclonal antibody, in relapsed/refractory cutaneous T-cell lymphomas.
    Bagot, Martine
    Duvic, Madeleine
    Vermeer, Maarten
    Porcu, Pierluigi
    Whittaker, Sean
    Ram-Wolff, Caroline
    Paiva, Christine
    Marie-Cardine, Anne
    Bonnafous, Cecile
    Paturel, Carine
    Moriette, Frederique
    Zerbib, Robert Albert
    Bensussan, Armand
    Sicard, Helene
    Pilz, Korinna
    Kim, Youn H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
    Bagot, Martine
    Porcu, Pierluigi
    Marie-Cardine, Anne
    Battistella, Maxime
    William, Basem M.
    Vermeer, Maarten
    Whittaker, Sean
    Rotolo, Federico
    Ram-Wolff, Caroline
    Khodadoust, Michael S.
    Bensussan, Armand
    Paturel, Carine
    Bonnafous, Cecile
    Sicard, Helene
    Azim, Hatem A., Jr.
    Kim, Youn H.
    LANCET ONCOLOGY, 2019, 20 (08): : 1160 - 1170
  • [5] Ex vivo and in vivo characterization of IPH4102, a humanized anti-KIR3DL2 antibody for the treatment of cutaneous T-cell lymphomas
    Marie-Cardine, Anne
    Viaud, Nicolas
    Dujardin, Arnaud
    Joly, Rachel
    Gauthier, Laurent
    Bonnafous, Cecile
    Blery, Mathieu
    Paturel, Carine
    Bensussan, Armand
    Bagot, Martine
    Sicard, Helene
    CANCER RESEARCH, 2014, 74 (19)
  • [6] First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results
    Bagot, Martine
    Porcu, Pierluigi
    Ram-Wolff, Caroline
    Khodadoust, Michael
    Battistella, Maxime
    Marie-Cardine, Anne
    Mathieu, Steve
    Vermeer, Maarten H.
    Whittaker, Sean
    Duvic, Madeleine
    Bensussan, Armand
    Paturel, Carine
    Bonnafous, Cecile
    Thonnart, Nicolas
    Widemann, Agnes
    Bonin, Cecile
    Sicard, Helene
    Paiva, Christine
    Pilz, Korinna
    Kim, Youn
    BLOOD, 2016, 128 (22)
  • [7] Anti-KIR3DL2 therapy in the treatment of Sezary syndrome
    Quaglino, Pietro
    LANCET ONCOLOGY, 2019, 20 (08): : 1048 - 1049
  • [8] A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies
    Sicard, Helene
    Bonnafous, Cecile
    Morel, Ariane
    Bagot, Martine
    Bensussan, Armand
    Marie-Cardine, Anne
    ONCOIMMUNOLOGY, 2015, 4 (09): : 1 - 2
  • [9] IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
    Van Der Weyden, Carrie
    Bagot, Martine
    Neeson, Paul
    Darcy, Phil K.
    Prince, H. Miles
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (08) : 691 - 697
  • [10] IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma
    Marie-Cardine, Anne
    Viaud, Nicolas
    Thonnart, Nicolas
    Joly, Rachel
    Chanteux, Stephanie
    Gauthier, Laurent
    Bonnafous, Cecile
    Rossi, Benjamin
    Blery, Mathieu
    Paturel, Carine
    Bensussan, Armand
    Bagot, Martine
    Sicard, Helene
    CANCER RESEARCH, 2014, 74 (21) : 6060 - 6070
12345